These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9443088)

  • 21. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium.
    Woerner SM; Givehchian M; Dürst M; Schneider A; Costa S; Melsheimer P; Lacroix J; Zöller M; Doeberitz MK
    Clin Cancer Res; 1995 Oct; 1(10):1125-32. PubMed ID: 9815903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and modulation of CD44 variant isoforms in humans.
    Mackay CR; Terpe HJ; Stauder R; Marston WL; Stark H; Günthert U
    J Cell Biol; 1994 Jan; 124(1-2):71-82. PubMed ID: 7507492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Splice variant expression of CD44 in patients with breast and ovarian cancer.
    Sanchez Lockhart M; Hajos SE; Basilio FM; Mongini C; Alvarez E
    Oncol Rep; 2001; 8(1):145-51. PubMed ID: 11115587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer.
    Kawano T; Yanoma S; Nakamura Y; Ozeki A; Kokatsu T; Kubota A; Furukawa M; Tsukuda M
    Acta Otolaryngol; 2005 Apr; 125(4):392-7. PubMed ID: 15823810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splice variants of CD44 in human cervical cancer stage IB to IIB.
    Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H
    Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyaluronidase can modulate expression of CD44.
    Stern R; Shuster S; Wiley TS; Formby B
    Exp Cell Res; 2001 May; 266(1):167-76. PubMed ID: 11339835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predominant expression of CD44 splice variant v10 in malignant and reactive human skin lymphocytes.
    Wagner SN; Wagner C; Reinhold U; Funk R; Zöller M; Goos M
    J Invest Dermatol; 1998 Sep; 111(3):464-71. PubMed ID: 9740242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of hormones on CD44 expression in endometrial and breast carcinomas.
    Durst B; Sorg RV; Röder G; Betz B; Beckmann MW; Niederacher D; Bender HG; Dall P
    Oncol Rep; 2001; 8(5):987-93. PubMed ID: 11496303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines.
    Stickeler E; Runnebaum IB; Möbus VJ; Kieback DG; Kreienberg R
    Anticancer Res; 1997; 17(3C):1871-6. PubMed ID: 9216637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD44 isoform expression follows two alternative splicing pathways in breast tissue.
    Roca X; Mate JL; Ariza A; Muñoz-Mármol AM; von Uexküll-Güldeband C; Pellicer I; Navas-Palacios JJ; Isamat M
    Am J Pathol; 1998 Jul; 153(1):183-90. PubMed ID: 9665479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva.
    Tempfer C; Gitsch G; Haeusler G; Reinthaller A; Koelbl H; Kainz C
    Cancer; 1996 Jul; 78(2):273-7. PubMed ID: 8674003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies.
    Salles G; Zain M; Jiang WM; Boussiotis VA; Shipp MA
    Blood; 1993 Dec; 82(12):3539-47. PubMed ID: 7505117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are CD44 variant isoforms involved in human tumour progression?
    Günthert U; Stauder R; Mayer B; Terpe HJ; Finke L; Friedrichs K
    Cancer Surv; 1995; 24():19-42. PubMed ID: 7553660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
    Abetamann V; Kern HF; Elsässer HP
    Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia.
    Legras S; Günthert U; Stauder R; Curt F; Oliferenko S; Kluin-Nelemans HC; Marie JP; Proctor S; Jasmin C; Smadja-Joffe F
    Blood; 1998 May; 91(9):3401-13. PubMed ID: 9558399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa.
    Heider KH; Dämmrich J; Skroch-Angel P; Müller-Hermelink HK; Vollmers HP; Herrlich P; Ponta H
    Cancer Res; 1993 Sep; 53(18):4197-203. PubMed ID: 7689929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relationship between the abnormal expression of CD44 gene and bladder cancer].
    Wu Z; Zhang Y; Liu D
    Zhonghua Wai Ke Za Zhi; 1996 Nov; 34(11):645-7. PubMed ID: 9590747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer.
    Huang CS; Shen CY; Wang HW; Wu PE; Cheng CW
    Clin Chim Acta; 2007 Sep; 384(1-2):69-74. PubMed ID: 17651715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression.
    Li H; Guo L; Li JW; Liu N; Qi R; Liu J
    Int J Oncol; 2000 Nov; 17(5):927-32. PubMed ID: 11029494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preferential overexpression of CD44v5 in advanced gastric carcinoma Goseki grades I and III.
    Stachura J; Krzeszowiak A; Popiela T; Urbańczyk K; Pituch-Noworolska A; Wieckiewicz J; Zembala M
    Pol J Pathol; 1999; 50(3):155-61. PubMed ID: 10624117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.